Patient tolerance to interferon: clinical and laboratory assessments.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Toxicity has been associated with interferon therapy, predominantly in immunocompromised patients. Side effects appear to be dose-related and were difficult to manage. However, interferon was well-tolerated and some of the toxicity may be related to the immunocompromised state.

Original languageEnglish
Pages (from-to)41-45
Number of pages5
JournalThe Medical clinics of North America
VolumeSuppl
StatePublished - May 1 1986
Externally publishedYes

Fingerprint

Interferons
Immunocompromised Host
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Patient tolerance to interferon : clinical and laboratory assessments. / Fischl, Margaret A.

In: The Medical clinics of North America, Vol. Suppl, 01.05.1986, p. 41-45.

Research output: Contribution to journalArticle

@article{bab8d88d37eb410792441446d037b865,
title = "Patient tolerance to interferon: clinical and laboratory assessments.",
abstract = "Toxicity has been associated with interferon therapy, predominantly in immunocompromised patients. Side effects appear to be dose-related and were difficult to manage. However, interferon was well-tolerated and some of the toxicity may be related to the immunocompromised state.",
author = "Fischl, {Margaret A}",
year = "1986",
month = "5",
day = "1",
language = "English",
volume = "Suppl",
pages = "41--45",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Patient tolerance to interferon

T2 - clinical and laboratory assessments.

AU - Fischl, Margaret A

PY - 1986/5/1

Y1 - 1986/5/1

N2 - Toxicity has been associated with interferon therapy, predominantly in immunocompromised patients. Side effects appear to be dose-related and were difficult to manage. However, interferon was well-tolerated and some of the toxicity may be related to the immunocompromised state.

AB - Toxicity has been associated with interferon therapy, predominantly in immunocompromised patients. Side effects appear to be dose-related and were difficult to manage. However, interferon was well-tolerated and some of the toxicity may be related to the immunocompromised state.

UR - http://www.scopus.com/inward/record.url?scp=0022709127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022709127&partnerID=8YFLogxK

M3 - Article

C2 - 2426535

AN - SCOPUS:0022709127

VL - Suppl

SP - 41

EP - 45

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

ER -